We continue on our journey through early stage breast cancer, this time turning our attention to HER2+ disease. There is a lot of data in this episode, as you will both hear and see. To make this easier, we highlight key takeaways to make understanding this even easier.

Content:

- What is HER2?

- Discovery of trastuzumab

- Data for use of trastuzumab in adjuvant and neoadjuvant setting

- Data for use of pertuzumab in adjuvant and neoadjuvant setting

- Data and use of trastuzumab emtansine (TDM-1) in the adjuvant setting

- Management of HER2+ stage I breast cancer

- Highlights of key trials that shape the paradigm of management

- Our approach to management

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer

The Fellow on Call: The Heme/Onc Podcast

Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer